The Efficacy of Moclobemide in Treatment of Major Depression
The effectiveness and the tolerence of moclobemde -one of the reversible inhibitors of MAO-A were assessed in an open clinical trial on 19 inpatients with major depression according to DSM.III and with a score of 16 or more on Hamilton Rating Scale of Depression (HRSD). As a result, a statistically...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Mesut Çetin
2021-03-01
|
| Saila: | Psychiatry and Clinical Psychopharmacology |
| Gaiak: | |
| Sarrera elektronikoa: | https://psychiatry-psychopharmacology.com/index.php/pub/article/view/106 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|